$2.92-0.03 (-1.02%)
iSpecimen Inc.
iSpecimen Inc. in the Healthcare sector is trading at $2.92 with a market capitalization of $4M. The stock is currently near its 52-week low of $2.75, remaining 84.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 29 is oversold, raising the odds of a near-term bounce. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $156,009β | $51,761β | $106,592β | $713,135β | $1.06M |
| Gross Profit | $71,599β | -$547,078β | -$98,001β | $268,958β | $400,231 |
| Operating Income | -$2.54Mβ | -$2.69Mβ | -$2.83Mβ | -$1.82Mβ | -$1.64M |
| Net Income | -$2.28Mβ | -$5.00Mβ | -$2.78Mβ | -$1.05Mβ | -$1.66M |
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platfo...
YY Group Holdings Ltd. 28,186,375 0.0743
US stocks looked set to open higher Friday as investors sifted through key inflation data and monito